Bryan Ball

Bryan Ball is a declared insider at 2 companies (senior executive); the most frequent names are Whitehawk Therapeutics, Inc. and Intercept Pharmaceuticals, Inc. The record holds 11 filings, for trades running from 11 January 2022 to 14 April 2026.

Sales make up the whole of the open-market record (4 sales, €535k). Besides market trades, the filings include 4 share grants and 3 option exercises. In 2026 alone, the filings show no purchases and 4 sales.

Most recently, on 15 April 2026, the filings show an open-market sale worth €285k in Whitehawk Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.